Tom Luedde

56PUBLICATIONS
331CO-AUTHORS
Industrial biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersEpidemiological methodsMedical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (56)

|Jul 06, 2026
Salmonella SopB suppresses post-transcriptionally regulated cytokine release to reduce early tissue inflammation and delay disease progression.

|Jul 01, 2026
Steatosis shapes prognosis-defining liver metastasis heterogeneity in CRC.

|Mar 31, 2026
Twelve‑month rehospitalization after IBD‑related hospitalization in Germany: A retrospective cohort study using administrative hospital data.

Christian Weigel, Sven H Loosen, Kaneschka Yaqubi

|Mar 28, 2026
Mechanisms of APOBEC3 Packaging into HIV-1.

Mirriam Nzivo, Christoph G W Gertzen, Tom Luedde

|Mar 26, 2026
Machine Learning Predicts Hepatocellular Carcinoma Risk from Routine Clinical Data: A Large Population-Based Multicentric Study.

Jan Clusmann, Paul-Henry Koop, David Y Zhang

|Feb 04, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki

Pageof 10

Frequent Collaborators

17 joint publications

Sven Loosen

9 joint publications

Mihael Vucur

8 joint publications

Frank Tacke

8 joint publications

Karel Kostev